Xu Kaijin, Cai Hongliu, Shen Yihong, Ni Qin, Chen Yu, Hu Shaohua, Li Jianping, Wang Huafen, Yu Liang, Huang He, Qiu Yunqing, Wei Guoqing, Fang Qiang, Zhou Jianying, Sheng Jifang, Liang Tingbo, Li Lanjuan
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.
The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance" strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients' blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance" strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as and , so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.
新型冠状病毒肺炎(COVID-19)当前疫情形势依然严峻。浙江大学医学院附属第一医院作为国家传染病临床研究中心,是浙江省COVID-19的主要医疗救治中心。基于国家卫生健康委员会和国家中医药管理局目前达成的专家共识,我们团队总结并制定了以“四抗二平衡”为核心的有效治疗策略用于临床实践。“四抗二平衡”策略包括抗病毒、抗休克、抗低氧血症、抗继发感染,以及维持水、电解质和酸碱平衡及微生态平衡。同时,建议采用多学科综合个体化治疗以提高治疗效果。临床决策中强调了早期病毒学检测、炎症指标动态监测及胸部影像学检查的重要性。痰标本RT-PCR结果阳性率最高。急性期10%的患者血液样本可检测到病毒核酸,50%的患者粪便RT-PCR结果呈阳性。我们还从粪便中分离出活病毒株,表明粪便具有潜在传染性。动态细胞因子检测对于及时识别细胞因子风暴及应用人工肝血液净化系统很有必要。“四抗二平衡”策略有效提高了治愈率并降低了死亡率。早期抗病毒治疗可减轻疾病严重程度并防止病情进展,我们发现洛匹那韦/利托那韦联合阿比多尔对COVID-19有抗病毒作用。休克和低氧血症通常由细胞因子风暴引起。人工肝血液净化系统可迅速清除炎症介质并阻断细胞因子风暴。此外,它还有利于维持液体、电解质和酸碱平衡,从而提高危重症的治疗效果。对于重症病例,支持早期且短期使用中等剂量糖皮质激素。氧合指数低于200 mmHg的患者应转至重症医学中心。首选保守氧疗,不建议无创通气。机械通气患者应严格实施预防呼吸机相关性肺炎的集束化策略。除病程长、反复发热及降钙素原(PCT)升高的患者外,不建议预防性使用抗菌药物,同时应关注继发真菌感染。部分COVID-19患者表现出肠道微生物群失调,益生菌如[具体益生菌名称1]和[具体益生菌名称2]减少,因此应对所有患者进行营养及胃肠功能评估。建议给予营养支持并应用益生元或益生菌以调节肠道微生物群平衡,降低细菌易位导致继发感染的风险。COVID-19患者中焦虑和恐惧很常见。因此,我们建立了心理危机动态评估与预警机制。我们还将中医融入治疗,通过中医辨证方法促进疾病康复。我们优化了重症患者的护理流程以促进其康复。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后病毒清除模式仍不清楚。因此,出院患者需要隔离两周并进行定期随访。浙江的经验和建议已在我们中心实施并取得了良好效果。然而,由于COVID-19是一种新出现的疾病,仍需要开展更多工作以完善COVID-19的预防、诊断和治疗策略。